SCHEMBL7278045

SCHEMBL7278045

CC(C)[C@H](N)C(=O)N(C(=O)OCc1ccccn1)C(Cc1ccccc1)C(O)C(F)(F)C(N)Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
PTGS1 P23219 1/20 0.41
SLC6A2 P23975 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
MAPT P10636 1/20 0.38
TSHR P16473 1/20 0.38
MAOB P27338 1/20 0.38
CA2 P00918 2/20 0.35
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34
RAB9A P51151 1/20 0.34
LNPEP Q9UIQ6 2/20 0.34
ABCB1 P08183 1/20 0.34
SLC1A5 Q15758 1/20 0.34
SLC15A1 P46059 1/20 0.33
CTSS P25774 1/20 0.33
CTSK P43235 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7268623 0.92 PGR (0.40) PGRADORA3PTGS1SLC6A2SMN1; SMN2
SCHEMBL7275895 0.88 PGR (0.47) PGRADORA3PTGS1SLC6A2SMN1; SMN2
SCHEMBL8536296 0.87 PGR (0.36) PGRADORA3PTGS1SLC6A2SMN1; SMN2
SCHEMBL6447678 0.87 PGR (0.46) PGRADORA3PTGS1SLC6A2SMN1; SMN2
SCHEMBL6445021 0.87 PGR (0.46) PGRADORA3PTGS1SLC6A2SMN1; SMN2
SCHEMBL6449059 0.87 PGR (0.46) PGRADORA3PTGS1SLC6A2SMN1; SMN2
SCHEMBL7270504 0.82 PGR (0.36) PGRADORA3PTGS1SLC6A2SMN1; SMN2
SCHEMBL7336658 0.81 PGR (0.41) PGRADORA3PTGS1SLC6A2SMN1; SMN2
SCHEMBL6449437 0.78 CA2 (0.44) CA2
SCHEMBL9741355 0.78 CA2 (0.44) CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 EP disclosed
US-5670675-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-09-23 US disclosed
US-5545750-A TREATING HUMAN IMMUNODEFICIENCY VIRUS ABBOTT LABORATORIES (US) 1996-08-13 US disclosed
EP-0402646-A1 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1990-12-19 EP disclosed